Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

444

Participants

Timeline

Start Date

June 19, 2020

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DRUG

Oral

Diltiazem 0.25mg/kg injection, give over 2 minutes, max dose 30mg

DRUG

Intravenous drug

these patients will receive traditional treatments at provider discretion. They must receive at least one intravenous medication for atrial fibrillation with rapid ventricular response. This will be a heterogenous group of patients receiving digoxin, amiodarone, various beta-blockers, and intravenous diltiazem without oral diltiazem.

Trial Locations (1)

49085

Matthew Hysell, Saint Joseph

All Listed Sponsors
lead

Spectrum Health - Lakeland

OTHER

NCT05391893 - Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation | Biotech Hunter | Biotech Hunter